Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study

Overview of attention for article published in Frontiers in Public Health, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 8,925 followers.

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China : An Interrupted #TimeSeries Study - @UCL Discovery https://t.co/IkMLHcxCkw H/T: @ucl_discovery https://t.co/cWO5dGF4OJ

16 Nov 2022

Reply Repost Favourite

Open Access UCL Research: Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study - UCL Discovery https://t.co/cP10L3PnCU

16 Nov 2022

Reply Repost Favourite

NRDLN National Reimbursement Drug List Negotiation https://t.co/3kGLFyuz3D https://t.co/W2xcNokYTn

25 Jul 2022

Reply Repost Favourite

RT @FrontPubHealth: New Research: Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in…

01 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.